JP2020504122A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020504122A5 JP2020504122A5 JP2019535810A JP2019535810A JP2020504122A5 JP 2020504122 A5 JP2020504122 A5 JP 2020504122A5 JP 2019535810 A JP2019535810 A JP 2019535810A JP 2019535810 A JP2019535810 A JP 2019535810A JP 2020504122 A5 JP2020504122 A5 JP 2020504122A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- aryl
- heteroaryl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc(cc1)ccc1N/C1=C\C*/C(/CC(CCCC2)CCN2c2cc(OC)ccc2)=N/C(/N)=N1 Chemical compound Cc(cc1)ccc1N/C1=C\C*/C(/CC(CCCC2)CCN2c2cc(OC)ccc2)=N/C(/N)=N1 0.000 description 5
- AQJLZOXYUHCQCV-UHFFFAOYSA-N CC(CCCc1ccc(C)cc1)CCc1nc(N)nc(Nc2ccccc2C)n1 Chemical compound CC(CCCc1ccc(C)cc1)CCc1nc(N)nc(Nc2ccccc2C)n1 AQJLZOXYUHCQCV-UHFFFAOYSA-N 0.000 description 2
- JUCGCZDYNSFCKZ-UHFFFAOYSA-N Cc(cc1)ccc1Nc1nc(CC2CCOCCCC2)nc(N)n1 Chemical compound Cc(cc1)ccc1Nc1nc(CC2CCOCCCC2)nc(N)n1 JUCGCZDYNSFCKZ-UHFFFAOYSA-N 0.000 description 1
- QYJQPVDGBPGYEX-UHFFFAOYSA-N Cc(cc1)ccc1Nc1nc(CN(CC2)c3c2cccc3)nc(N)n1 Chemical compound Cc(cc1)ccc1Nc1nc(CN(CC2)c3c2cccc3)nc(N)n1 QYJQPVDGBPGYEX-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382672 | 2016-12-29 | ||
| EP16382672.0 | 2016-12-29 | ||
| PCT/IB2017/058477 WO2018122775A1 (en) | 2016-12-29 | 2017-12-28 | Heteroaryl compounds and their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020504122A JP2020504122A (ja) | 2020-02-06 |
| JP2020504122A5 true JP2020504122A5 (enExample) | 2021-02-12 |
| JP7171057B2 JP7171057B2 (ja) | 2022-11-15 |
Family
ID=57708486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019535810A Active JP7171057B2 (ja) | 2016-12-29 | 2017-12-28 | ヘテロアリール化合物およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11174242B2 (enExample) |
| EP (1) | EP3562811B1 (enExample) |
| JP (1) | JP7171057B2 (enExample) |
| CN (1) | CN110325516A (enExample) |
| AU (1) | AU2017388466B2 (enExample) |
| BR (1) | BR112019013571A2 (enExample) |
| CA (1) | CA3048357A1 (enExample) |
| IL (1) | IL267626B2 (enExample) |
| WO (1) | WO2018122775A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3048357A1 (en) | 2016-12-29 | 2018-07-05 | Minoryx Therapeutics S.L. | Heteroaryl compounds and their use |
| WO2020104578A2 (en) * | 2018-11-21 | 2020-05-28 | University Of Copenhagen | Modulators of free fatty acid receptor 1 and their use for treatment of diseases |
| BR112022010126A2 (pt) * | 2019-11-25 | 2022-09-06 | Gain Therapeutics Sa | Compostos de heteroarila e usos terapêuticos dos mesmos em condições associadas à alteração da atividade da betaglucocerebrosidase |
| WO2021183596A1 (en) * | 2020-03-10 | 2021-09-16 | University Of Cincinnati | Materials and methods for the treatment of gaucher disease |
| WO2024206067A2 (en) * | 2023-03-24 | 2024-10-03 | Purdue Research Foundation | Symmetric aminoindole-linked triazine for a dual effect on alpha-synuclein and tau isoform 2n4r fibrillization |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6492372B1 (en) * | 1999-01-22 | 2002-12-10 | Elan Pharmaceuticals, Inc. | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| MXPA03005120A (es) | 2000-12-07 | 2004-03-10 | Cv Therapeutics Inc | Compuestos para el incremento de abca-1. |
| CA2672805A1 (en) * | 2001-01-31 | 2002-08-08 | H. Lundbeck A/S | Pyrimidine derivatives |
| WO2002060392A2 (en) | 2001-01-31 | 2002-08-08 | Synaptic Pharmaceutical Corporation | Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| US6924290B2 (en) | 2002-01-23 | 2005-08-02 | Bayer Pharmaceuticals Corporation | Rho-kinase inhibitors |
| US7737153B2 (en) | 2002-10-28 | 2010-06-15 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| CN1199946C (zh) | 2002-10-29 | 2005-05-04 | 无锡杰西医药科技有限公司 | 一种特异性吲哚类化合物及制备方法与其在治疗和预防癌症等疾病中的应用 |
| KR20080004585A (ko) * | 2005-04-08 | 2008-01-09 | 바이엘 파마슈티칼스 코포레이션 | 피리미딘 유도체 및 암의 치료에서의 이의 용도 |
| BRPI0615880A2 (pt) | 2005-09-13 | 2011-05-31 | Palau Pharma Sa | compostos derivados de 2-aminopirimidina como moduladores da atividade de receptor da histamina h4, uso dos mesmos e composição farmacêutica |
| JP5337405B2 (ja) | 2007-09-17 | 2013-11-06 | ザ・ホスピタル・フォー・シック・チルドレン | ゴーシェ病の治療方法 |
| US8138356B2 (en) | 2007-10-16 | 2012-03-20 | Angiogeney, Inc. | Chemical inhibitors of inhibitors of differentiation |
| US8642660B2 (en) * | 2007-12-21 | 2014-02-04 | The University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| US20130023498A1 (en) * | 2008-02-20 | 2013-01-24 | The Wistar Institute and North Carolina State University | MicroRNA Modulators and Method for Identifying and Using the Same |
| US8119637B2 (en) * | 2008-06-10 | 2012-02-21 | Plexxikon Inc. | Substituted pyrrolo[2,3-b]pyrazines and methods for kinase modulation, and indications therefor |
| PT2995306T (pt) | 2009-10-19 | 2019-03-29 | Amicus Therapeutics Inc | Novas composições para prevenção e/ou tratamento de disfunções de armazenamento lisossomal |
| WO2012035055A1 (en) * | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
| CN103917094B (zh) | 2011-03-18 | 2016-11-09 | 建新公司 | 葡萄糖基神经酰胺合酶抑制剂 |
| US9845327B2 (en) | 2011-06-22 | 2017-12-19 | The General Hospital Corporation | Treatment of proteinopathies |
| WO2013059119A1 (en) | 2011-10-17 | 2013-04-25 | The Regents Of The University Of Michigan | Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| CA2868459A1 (en) | 2012-03-27 | 2013-10-03 | Amicus Therapeutics, Inc. | Polymorphs of (3r,4r,5s)-5-(difluoromethyl)piperidine-3,4-diol fumarate and uses thereof |
| CN104918616A (zh) * | 2012-10-24 | 2015-09-16 | 格卢科克斯生物科技有限公司 | 用于治疗与烟酰胺腺嘌呤二核苷酸磷酸氧化酶相关的病况的三嗪衍生物 |
| EP3027590A1 (en) | 2013-07-31 | 2016-06-08 | Minoryx Therapeutics S.L. | Di(hetero)arylamides and sulfonamides, methods for their preparation and therapeutic uses thereof |
| AU2015217185B2 (en) * | 2014-02-12 | 2018-04-05 | Purdue Pharma L.P. | Isoquinoline derivatives and use thereof |
| CN107001379B (zh) | 2014-11-06 | 2022-11-01 | Bial研发投资股份有限公司 | 取代的吡唑并[1,5-a]嘧啶以及它们在治疗医学障碍中的用途 |
| WO2016120808A1 (en) | 2015-01-28 | 2016-08-04 | Minoryx Therapeutics S.L. | Heteroarylaminoisoquinolines, methods for their preparation and therapeutic uses thereof |
| JP2018505226A (ja) * | 2015-02-16 | 2018-02-22 | グルコックス・バイオテック・アーベー | Ｎ２−（３，４−ジメチルフェニル）−６−（（４−（ｐ−トリル）ピペラジン−１−イル）メチル）−１，３，５−トリアジン−２，４−ジアミン |
| BR112017022032A2 (pt) * | 2015-04-15 | 2018-07-03 | Biomarin Pharm Inc | métodos para tratamento de transtornos de armazenamento lisossômico |
| WO2017031116A1 (en) | 2015-08-18 | 2017-02-23 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Small molecule inhibitors of ku70/80 and uses thereof |
| CN105412114A (zh) * | 2015-12-11 | 2016-03-23 | 卢璐娇 | 6-{[4-(2-氟苯基)1-哌嗪基]甲基}-n-(萘基)-1,3,5-三嗪-2,4-二胺在制备血管生成抑制剂中的应用 |
| CA3048357A1 (en) | 2016-12-29 | 2018-07-05 | Minoryx Therapeutics S.L. | Heteroaryl compounds and their use |
-
2017
- 2017-12-28 CA CA3048357A patent/CA3048357A1/en active Pending
- 2017-12-28 JP JP2019535810A patent/JP7171057B2/ja active Active
- 2017-12-28 US US16/474,461 patent/US11174242B2/en active Active
- 2017-12-28 WO PCT/IB2017/058477 patent/WO2018122775A1/en not_active Ceased
- 2017-12-28 EP EP17829719.8A patent/EP3562811B1/en active Active
- 2017-12-28 AU AU2017388466A patent/AU2017388466B2/en not_active Ceased
- 2017-12-28 CN CN201780086577.0A patent/CN110325516A/zh active Pending
- 2017-12-28 BR BR112019013571-5A patent/BR112019013571A2/pt not_active IP Right Cessation
-
2019
- 2019-06-25 IL IL267626A patent/IL267626B2/en unknown
-
2021
- 2021-10-06 US US17/495,542 patent/US11739072B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016299485B2 (en) | 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same | |
| JP2020519606A5 (enExample) | ||
| JP2020504711A5 (enExample) | ||
| JP2016534134A5 (enExample) | ||
| JP2020503297A5 (enExample) | ||
| HUP0401876A2 (hu) | Béta2 adrenerg receptor agonista hatású aril-anilin-származékok, valamint ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| JPH11193281A (ja) | アデノシンａ３受容体拮抗剤およびチアゾール化合物 | |
| NO900991D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater | |
| JP2008513515A5 (enExample) | ||
| JP2005513026A5 (enExample) | ||
| JP2020533352A5 (enExample) | ||
| BR112012032813A2 (pt) | composto, composição farmacêutica, e, método para prevenir, tratar ou melhorar uma doença ou condição. | |
| RU2017145930A (ru) | МОДУЛЯТОРЫ ROR ГАММА (RORγ) | |
| BR112023025599A2 (pt) | Ativadores de dimetoxifenilalquilamina de receptores de serotonina. | |
| JP2013542267A5 (enExample) | ||
| CN111601797A (zh) | 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用 | |
| JPWO2023195529A5 (enExample) | ||
| CA2730471A1 (en) | Piperazine derivatives used as cav2.2 calcium channel modulators | |
| RU2006138426A (ru) | Производные тиазолопиридина, содержащие их фармацевтические композиции и способы лечения состояний, опосредованных глюкокиназой | |
| CA2618511A1 (en) | Novel benzothiazolone derivatives | |
| CA2405408A1 (en) | Pyrazole compounds | |
| HRP20041087B1 (hr) | Derivati n-acilaminobenzena kao selektivni inhibitori monoamin oksidaze b | |
| JP2020111571A5 (enExample) | ||
| US20020049205A1 (en) | Pyrazole antimicrobial agents | |
| JP2004521913A5 (enExample) |